Search Articles

View query in Help articles search

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS


A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection

A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection

Despite a few successes using biomarkers for targeted therapy, ICS choice, especially in the primary care setting, is largely by trial and error and many patients remain uncontrolled [37-42]. Besides patient nonadherence and environmental factors, response to ICS treatment is affected by genetic variations in ICS metabolizing enzymes [43,44], regardless of whether the ICS is used alone or is combined with another asthma medication like a long-acting beta2 agonist.

Flory L Nkoy, Bryan L Stone, Yue Zhang, Gang Luo

JMIR Med Inform 2024;12:e56572

Clinical Outcomes After Use of Inhaled Corticosteroids or Oral Steroids in a COVID-19 Telemedicine Clinic Cohort: Retrospective Chart Review

Clinical Outcomes After Use of Inhaled Corticosteroids or Oral Steroids in a COVID-19 Telemedicine Clinic Cohort: Retrospective Chart Review

Additionally, there was a relative reduction of 91% in clinical deterioration among study patients receiving ICS. Therefore, evaluation of the use of ICS in the treatment of outpatient COVID-19 and long-term outcomes is advised.

Michele Cellai, Jodi Roberts, Miranda A Moore, Nikhila Gandrakota

JMIR Form Res 2023;7:e36023